Boston Scientific Corporation (BSX)
Boston Scientific Corporation Receivables Turnover: 5.846
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
BSX Receivables Turnover Rankings
| Overall | 33rd percentile | 2296 of 3458 |
| Sector | 38th percentile | 239 of 391 in Healthcare |
| Industry | 43rd percentile | 39 of 69 in Medical Appliances & Equipment |
BSX Receivables Turnover Range, Past 5 Years
| Minimum | 5.581 | Jun 2008 |
| Maximum | 5.941 | Sep 2011 |
| Average | 5.774 |
About Receivables Turnover Ratio
The receivable turnover ratio quantifies a company's ability to collect liabilities/debts. It helps investors gauge the efficiency of a company's collection and credit policies.
A high ratio value indicates an efficient and effective credit policy, and a low ratio indicates a debt collection problem.
The way to read the receivables turnover ratio is as follows. Assume that a company has a receivables turnover ratio of 10. We say that "the company turns over its receivables 10 times during the year." In other words, on average the company collects its outstanding receivables 10 times per year.
Learn More
You may also be interested in these BSX related companies
BSX News
Pre-Open Movers 5/18: (PSUN) (WGO) (CRM) Higher; (ADSK) (SQNM) (ARUN) Lower (more...)
May 18, 9:28AM Street Insider
May 18, 9:28AM Street Insider
Boston Scientific Endoscopy Presents Promising Clinical Data During Digestive Disease Week ®
May 18, 8:30AM PR Newswire
May 18, 8:30AM PR Newswire
Boston Scientific (BSX) Reports Encouraging Data from PROMUS Element Study;
May 18, 6:52AM Street Insider
May 18, 6:52AM Street Insider
After-Hours Movers 05/17: (PSUN) (OSIR) (CRM) (BSX) Higher; (SQNM) (ARUN) (SIRI) Lower
May 17, 5:40PM Street Insider
May 17, 5:40PM Street Insider
Boston Scientific (BSX) Ticks Higher Following FDA Approval of Stent System
May 17, 5:30PM Street Insider
May 17, 5:30PM Street Insider
$BSX Boston Scientific Announces FDA Approval and U.S. Launch of EPIC Vascular Stent
about 10 days ago by RSInvest
about 10 days ago by RSInvest
Boston Scientific (BSX) Gets FDA Approval for Epic Vascular Self-Expanding Stent System
May 17, 5:16PM Street Insider
May 17, 5:16PM Street Insider
Boston Scientific Announces FDA Approval and U.S. Launch of EPIC Vascular Stent
May 17, 5:16PM Benzinga
May 17, 5:16PM Benzinga
Boston Scientific Announces FDA Approval and U.S. Launch of EPIC™ Vascular Stent
May 17, 5:14PM PR Newswire
May 17, 5:14PM PR Newswire
$STXS raises 18.5M to pay down credit facility and for general corporate purposes http://stks.co/3r3z $JNJ $BSX $HNSN
about 12 days ago by ATandon_STE
about 12 days ago by ATandon_STE
Boston Scientific Announces Positive Data from Lotus Transcatheter Aortic Valve Trial
May 15, 12:46PM Benzinga
May 15, 12:46PM Benzinga
Boston Scientific (BSX) Reports Encouraging Data from REPRISE I Feasibility
May 15, 11:11AM Street Insider
May 15, 11:11AM Street Insider
Boston Scientific Announces Positive Data From Lotus™ Transcatheter Aortic Valve Trial
May 15, 11:00AM Benzinga
May 15, 11:00AM Benzinga
UPDATE: Citigroup Reiterates Neutral Rating, Raises PT for Boston Scientific
May 14, 11:33AM Benzinga
May 14, 11:33AM Benzinga
Boston Scientific (BSX), Philips (PHG) Enter Imaging Equipment Sales Agreement
May 14, 8:33AM Street Insider
May 14, 8:33AM Street Insider
I have a $BSX bond maturing in 2035 at 122w 7% coupon. The stock can't get out of its way. Cuckoo! It's called a bubble.
about 26 days ago by frotuss
about 26 days ago by frotuss
$BSX http://stks.co/3Y6W Watching for a break above this downtrend line.
about 31 days ago by jamiemc101
about 31 days ago by jamiemc101
Great to be spot on with $bsx, predicted over 6 ands its already well above. Sold some calls not sure if we see 7 just yet
about 31 days ago by frankdatrader
about 31 days ago by frankdatrader
Sold bunch of calls on my $bsx time to take profit again, not sure we r gonna break just yet.
about 33 days ago by frankdatrader
about 33 days ago by frankdatrader
$BSX closing above $6 a big deal. Getting ready to golden cross. Big winner if Obamacare reversed.
about 33 days ago by mattowan
about 33 days ago by mattowan
My God! When did $BSX become a $5 stock? Last time I looked, it was $40 or something. #BadTrader $$
about 35 days ago by Shoofly7
about 35 days ago by Shoofly7
Leerink analyst says $BSX Cognis defibrillator linked to a death, says device risk "relatively minor"
about 35 days ago by Street_Insider
about 35 days ago by Street_Insider
I didn't see anything in the $BSX report that argues for investing in anything to do with medical devices these days.
about 38 days ago by bradloncar
about 38 days ago by bradloncar
Listen to $BSX Q1 2012 earnings call - live at 08:00 AM, ondemand after - http://stks.co/3PVl
about 39 days ago by earningscast
about 39 days ago by earningscast
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| BSX | 5.87 | -0.04 | -0.68% | 8.516B |
| BOBE | 40.44 | -0.13 | -0.32% | 1.189B |
| BNZ | 21.20 | +0.10 | +0.49% | |
| BNY | 16.28 | +0.04 | +0.25% | |
| BNVI | 0.116 | +0.00 | +0.00% | |
| BNS | 49.49 | -0.58 | -1.16% | 53.92B |
| BNHN | 16.13 | +0.00 | +0.00% | 288.40M |
| BMRN | 38.64 | +0.13 | +0.34% | 4.468B |
| BMR | 18.25 | -0.17 | -0.92% | 2.815B |
| BMO | 52.99 | -0.73 | -1.36% | 33.94B |
